"Chemokine CCL22" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR4 RECEPTORS. It has activity towards TH2 CELLS and TC2 CELLS.
| Descriptor ID |
D054422
|
| MeSH Number(s) |
D12.644.276.374.200.110.900 D12.776.467.374.200.110.900 D23.125.300.110.900 D23.469.200.110.900 D23.529.374.200.110.900
|
| Concept/Terms |
Chemokine CCL22- Chemokine CCL22
- CCL22, Chemokine
- CCL22 Chemokine
- Chemokine, CCL22
- Stimulated T Cell Chemotactic Protein 1
- SCYA22 Chemokine
- Chemokine, SCYA22
- Small Inducible Cytokine A22
- CC Chemokine STCP-1
- CC Chemokine STCP 1
- Chemokine STCP-1, CC
- STCP-1, CC Chemokine
- Macrophage-Derived Chemokine
- Chemokine, Macrophage-Derived
- Macrophage Derived Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL22".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL22".
This graph shows the total number of publications written about "Chemokine CCL22" by people in this website by year, and whether "Chemokine CCL22" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL22" by people in Profiles.
-
Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):1034-1043.
-
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment. J Immunol. 2013 Jun 15; 190(12):6681-93.
-
Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol. 2010 Mar 15; 184(6):2999-3007.
-
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model. Blood. 2009 Jun 18; 113(25):6392-402.
-
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res. 2008 Jul 15; 68(14):5972-8.
-
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol Immunother. 2008 Jan; 57(1):123-31.
-
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood. 2004 Aug 15; 104(4):1066-74.